Roivant Sciences Ltd at Sanford C Bernstein Healthcare Leaders and Disruptors Healthcare Forum Summary - Thomson StreetEvents

Roivant Sciences Ltd at Sanford C Bernstein Healthcare Leaders and Disruptors Healthcare Forum Summary

Roivant Sciences Ltd at Sanford C Bernstein Healthcare Leaders and Disruptors Healthcare Forum Summary - Thomson StreetEvents
Roivant Sciences Ltd at Sanford C Bernstein Healthcare Leaders and Disruptors Healthcare Forum Summary
Published Sep 23, 2025
15 pages (9706 words) — Published Sep 23, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of ROIV.OQ presentation 23-Sep-25 6:00pm GMT

  
Brief Excerpt:

...A. We've got about a $10 billion market cap, about $4.5 billion of cash after the sale of the drug to Roche a few years back. B. And one of our programs is a public subsidiary, Immunovant, an anti-FcRn antibody. C. I'm sure we'll talk about that one too, but that has about a $2 billion market value for our stake....

  
Report Type:

Brief

Source:
Company:
Roivant Sciences Ltd
Ticker
ROIV.OQ
Time
6:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Roivant Sciences Ltd Q2 2025 Earnings Call Summary – 2025-11-10 – US$ 54.00 – Edited Brief of ROIV.OQ earnings conference call or presentation 10-Nov-25 1:00pm GMT

Roivant Sciences Ltd Q2 2025 Earnings Call Transcript – 2025-11-10 – US$ 54.00 – Edited Transcript of ROIV.OQ earnings conference call or presentation 10-Nov-25 1:00pm GMT

Roivant Sciences Ltd at Bank of America Global Healthcare Conference Summary – 2025-09-24 – US$ 54.00 – Edited Brief of ROIV.OQ presentation 24-Sep-25 9:45am GMT

Roivant Sciences Ltd at Bank of America Global Healthcare Conference Transcript – 2025-09-24 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 24-Sep-25 9:45am GMT

Roivant Sciences Ltd at Sanford C Bernstein Healthcare Leaders and Disruptors Healthcare Forum Transcript – 2025-09-23 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 23-Sep-25 6:00pm GMT

Roivant Sciences Ltd Brepocitinib in DM: VALOR Phase 3 Study Results Summary – 2025-09-17 – US$ 54.00 – Edited Brief of ROIV.OQ conference call or presentation 17-Sep-25 12:00pm GMT

Roivant Sciences Ltd Brepocitinib in DM: VALOR Phase 3 Study Results Transcript – 2025-09-17 – US$ 54.00 – Edited Transcript of ROIV.OQ conference call or presentation 17-Sep-25 12:00pm GMT

Roivant Sciences Ltd at HC Wainwright Global Investment Conference Summary – 2025-09-09 – US$ 54.00 – Edited Brief of ROIV.OQ presentation 9-Sep-25 6:00pm GMT

Roivant Sciences Ltd at HC Wainwright Global Investment Conference Transcript – 2025-09-09 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 9-Sep-25 6:00pm GMT

Roivant Sciences Ltd at Morgan Stanley Global Healthcare Conference Summary – 2025-09-08 – US$ 54.00 – Edited Brief of ROIV.OQ presentation 8-Sep-25 9:35pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Roivant Sciences Ltd at Sanford C Bernstein Healthcare Leaders and Disruptors Healthcare Forum Summary" Sep 23, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Roivant-Sciences-Ltd-at-Sanford-C-Bernstein-Healthcare-Leaders-and-Disruptors-Healthcare-Forum-B16511849>
  
APA:
Thomson StreetEvents. (2025). Roivant Sciences Ltd at Sanford C Bernstein Healthcare Leaders and Disruptors Healthcare Forum Summary Sep 23, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Roivant-Sciences-Ltd-at-Sanford-C-Bernstein-Healthcare-Leaders-and-Disruptors-Healthcare-Forum-B16511849>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.